OPTIMISE clinical trial targets high-risk childhood cancers
The OPTIMISE clinical trial, a collaborative effort between Canada and Australia, is providing new hope for children, adolescents, and young adults facing high-risk, hard-to-treat cancers. The trial is designed to match patients with targeted therapies based on the specific genetic makeup of their tumours.
One participant, seven-year-old Beckett Tessarolo from British Columbia, has seen significant progress following his diagnosis of acute lymphoblastic leukemia (ALL). After being diagnosed as an infant, Beckett underwent an intensive eight-month hospital treatment phase as part of the trial's initial stages.
The initiative was highlighted during Childhood Cancer Awareness Month to draw attention to the potential of precision medicine in treating pediatric oncology cases.
Entities
Australia · BC Children's Hospital · BC Children’s Hospital · Beckett Tessarolo · Canada · OPTIMISE
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 7 SOURCES] The trial matches patients to therapies based on the genetic makeup of their tumors. westknews.com · lakecountrycalendar.com · mapleridgenews.com · peninsulanewsreview.com · pentictonwesternnews.com · +2 more
- [● 7 SOURCES] Beckett Tessarolo spent eight months in the hospital receiving treatment during the initial phase of a clinical trial. westknews.com · lakecountrycalendar.com · mapleridgenews.com · peninsulanewsreview.com · pentictonwesternnews.com · +2 more
- [● 7 SOURCES] The OPTIMISE clinical trial is being conducted across Canada in collaboration with Australia. westknews.com · lakecountrycalendar.com · mapleridgenews.com · peninsulanewsreview.com · pentictonwesternnews.com · +2 more
- [● 7 SOURCES] Beckett Tessarolo was diagnosed with acute lymphoblastic leukemia (ALL). westknews.com · lakecountrycalendar.com · mapleridgenews.com · peninsulanewsreview.com · pentictonwesternnews.com · +2 more